Veterinary Sutures Market Forecast Through 2035: Manufacturers Focus on Veterinary-Specific Innovation

The global veterinary sutures market is expected to expand as animal healthcare providers respond to increasing surgical requirements and changing expectations among pet owners. The market was valued at USD 368.4 million in 2025 and is projected to reach USD 542.6 million by 2035, representing a CAGR of 4.0% during the forecast period. Growing companion animal ownership, increased use of veterinary surgical services, and demand for specialized wound closure materials are among the principal factors supporting this outlook.

Veterinary sutures are used to close surgical incisions and wounds across a variety of procedures. Their characteristics influence tissue support, wound management, and postoperative care. As veterinary practices handle a wider range of routine and specialized interventions, suppliers must provide products that meet differing surgical requirements. This creates opportunities for established medical device companies as well as manufacturers developing products specifically for animal healthcare.

View the complete veterinary sutures market report and forecast:https://www.clarivanthealth.com/report/veterinary-sutures-market 

Veterinary Surgery Creates Recurring Product Demand

The number and variety of veterinary surgical procedures are important determinants of suture consumption. Spaying and neutering procedures generate regular demand because they are commonly performed in companion animal practice. Orthopaedic and soft-tissue surgeries further contribute to demand, with product selection influenced by the surgical site, the tissue involved, and the support required during healing.

Rising pet humanization is helping sustain this activity. Owners increasingly seek professional veterinary treatment for their dogs and cats, including procedures intended to address injuries and other medical conditions. This trend supports demand for surgical supplies used in general veterinary clinics and specialist facilities.

Pet insurance may also affect decisions about treatment and product selection. When insurance reduces the cost burden for eligible procedures, owners may be more willing to authorize surgery and the wound closure materials recommended by their veterinarians. This can support demand for premium absorbable and antimicrobial sutures in some companion animal practices. However, differences in insurance coverage and household budgets mean the impact varies between markets.

Product Design and Material Selection Influence Adoption

Absorbable sutures account for the largest revenue share among product types in the supplied market analysis. They gradually break down within the body, potentially eliminating the need for a separate removal visit when the material is appropriate for the procedure. This can simplify follow-up care for owners and veterinary practices, particularly when transporting an animal back to a clinic is inconvenient.

Non-absorbable sutures remain necessary for procedures requiring sustained support. They retain clinical relevance in selected orthopaedic and other surgical applications, where veterinarians must choose materials based on the requirements of the operation.

Synthetic absorbable sutures also represent a significant material category. Compared with certain natural absorbable alternatives, they can offer more predictable resorption characteristics and reduced tissue reaction. These properties contribute to their use in surgical settings where predictable material performance is important. Product choice nevertheless depends on clinical judgment and the specific needs of each procedure.

Dedicated Veterinary Products Attract Industry Attention

A notable market development is the increasing focus on products designed specifically for veterinary surgery rather than adapted from human medical applications. Veterinary practices have historically sourced some sutures through human surgical supply channels. Dedicated products give manufacturers an opportunity to address animal-specific requirements and establish more direct relationships with veterinary customers.

The supplied report identifies two recent developments. Olympus Corporation enhanced suture delivery systems used in veterinary laparoscopic surgeries in December 2025. Nipro Corporation introduced a line of biocompatible surgical sutures tailored to veterinary applications in January 2026. These developments indicate activity in both the delivery of sutures during procedures and the materials used for surgical closure.

Purpose-built products may help manufacturers distinguish their offerings from conventional alternatives. However, successful adoption depends on practical benefits, product availability, price, and veterinarians' confidence in the supporting evidence. The report identifies limited veterinary-specific clinical evidence as a restraint, since newer technologies may have more extensive documentation from human surgery than from animal procedures.

Competitive Landscape and Regional Opportunities

The veterinary sutures market includes established medical device companies and specialized suppliers. Key participants identified in the supplied report include B. Braun Melsungen AG, Ethicon (Johnson & Johnson), Medtronic plc, Neogen Corporation, CP Medical, Nipro Corporation, Olympus Corporation, DemeTECH Corporation, Vitrex Medical A/S, Air-Tite Products Co., AIP Medical SA, Corza Medical, KATSAN Katgüt Sanayi ve Tic. A.Ş., and ProNorth Medical.

B. Braun held more than 22.6% of the global market in 2025, according to the report. The five leading manufacturers collectively accounted for 68.7%, indicating that a substantial portion of market revenue is concentrated among established suppliers.

North America recorded the largest regional revenue share in 2025. Its developed companion animal healthcare sector, specialty veterinary referral centres, and pet insurance penetration support demand for surgical materials. Europe is expected to grow steadily, with Germany, France, the United Kingdom, and Italy representing important markets.

Asia Pacific is projected to register rapid growth. Japan's veterinary-specific product development and expanding companion animal healthcare infrastructure in China and India are among the factors supporting regional opportunities. Latin America and the Middle East and Africa are expected to experience more moderate growth, with product access and purchasing power influencing demand.

Request a sample report to explore the market scope and segmentation: https://www.clarivanthealth.com/report/veterinary-sutures-market/sample-request  

Cost Pressures Continue to Shape Purchasing Decisions

Affordability remains a constraint, particularly in livestock and production-animal practice. The economics of treating a production animal may not support the same spending on premium materials as companion animal surgery. Consequently, conventional sutures may remain more attractive in cost-sensitive settings.

Competition from human-grade suture products also creates challenges for dedicated veterinary suppliers. Clinics may continue using existing products if they meet clinical needs and offer favorable pricing. To encourage switching, veterinary-specific manufacturers need to demonstrate product suitability and practical advantages while addressing concerns about clinical evidence.